Literature DB >> 19615360

The role of HGF on invasive properties and repopulation potential of human fetal hepatic progenitor cells.

Jean-Paul Delgado1, Valérie Vanneaux, Julie Branger, Thomas Touboul, Loïc Sentilhes, Sylvie Mainot, Panagiotis Lainas, Philippe Leclerc, Georges Uzan, Dominique Mahieu-Caputo, Anne Weber.   

Abstract

UNLABELLED: The success of hepatocyte transplantation has been limited by the low efficiency of transplanted cell integration into liver parenchyma. Human fetal hepatic progenitor cells (hepatoblasts) engraft more effectively than adult hepatocytes in mouse livers. However, the signals required for their integration are not yet fully understood. We investigated the role of HGF on the migration and invasive ability of human hepatic progenitors in vitro and in vivo. Hepatoblasts were isolated from the livers of human fetuses between 10 and 12 weeks of gestation. Their invasive ability was assessed in the presence or absence of HGF. These cells were also transplanted into immunodeficient mice and analyzed by immunohistochemistry. In contrast to TNF-alpha, HGF increased the motogenesis and invasiveness of hepatoblasts, but not of human adult hepatocytes, via phosphorylation of extracellular signal-regulated kinase (ERK) 1/2. The invasive ability of human hepatoblasts correlated with the expression and secretion of matrix metalloproteinases (MMPs). Hepatoblasts stimulated with HGF prior transplantation into newborn mice migrated from the portal area into the hepatic parenchyma.
CONCLUSIONS: In contrast to adult hepatocytes, hepatoblasts display invasive ability that can be modulated by HGF in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615360     DOI: 10.1016/j.yexcr.2009.07.007

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  5 in total

1.  Growth factor- and cytokine-driven pathways governing liver stemness and differentiation.

Authors:  Aránzazu Sánchez; Isabel Fabregat
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

2.  Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice.

Authors:  Tanuja L Gutti; Jaclyn S Knibbe; Edward Makarov; Jinjin Zhang; Govardhana R Yannam; Santhi Gorantla; Yimin Sun; David F Mercer; Hiroshi Suemizu; James L Wisecarver; Natalia A Osna; Tatiana K Bronich; Larisa Y Poluektova
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

3.  Transplantation of hESC-derived hepatocytes protects mice from liver injury.

Authors:  Laia Tolosa; Jérôme Caron; Zara Hannoun; Marc Antoni; Silvia López; Deborah Burks; Jose Vicente Castell; Anne Weber; Maria-Jose Gomez-Lechon; Anne Dubart-Kupperschmitt
Journal:  Stem Cell Res Ther       Date:  2015-12-12       Impact factor: 6.832

Review 4.  Human pluripotent stem cells for modelling human liver diseases and cell therapy.

Authors:  Noushin Dianat; Clara Steichen; Ludovic Vallier; Anne Weber; Anne Dubart-Kupperschmitt
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

5.  Paired CRISPR/Cas9 Nickases Mediate Efficient Site-Specific Integration of F9 into rDNA Locus of Mouse ESCs.

Authors:  Yanchi Wang; Junya Zhao; Nannan Duan; Wei Liu; Yuxuan Zhang; Miaojin Zhou; Zhiqing Hu; Mai Feng; Xionghao Liu; Lingqian Wu; Zhuo Li; Desheng Liang
Journal:  Int J Mol Sci       Date:  2018-10-05       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.